SCHEMBL283769

SCHEMBL283769

NS(=O)(=O)c1ccc(O)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 17/20 1.00
CA1 P00915 11/20 1.00
CA12 O43570 9/20 1.00
CA9 Q16790 9/20 1.00
CA7 P43166 7/20 0.75
PTGS2 P35354 2/20 0.60
PTGS1 P23219 1/20 0.60
CA6 P23280 6/20 0.59
CA5A P35218 6/20 0.59
CA5B Q9Y2D0 6/20 0.59
CA14 Q9ULX7 5/20 0.59
CA4 P22748 4/20 0.59
CA13 Q8N1Q1 3/20 0.59
USP2 O75604 1/20 0.59
TSHR P16473 1/20 0.59
TDP1 Q9NUW8 1/20 0.59
AGO2 Q9UKV8 1/20 0.59
LMNA P02545 1/20 0.59
CA3 P07451 4/20 0.56
ENPP2 Q13822 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL29969444 0.97 CA2 (0.95) CA2CA1CA12CA9CA7
SCHEMBL11023570 0.97 CA2 (0.95) CA2CA1CA12CA9CA7
SCHEMBL28323146 0.87 CA2 (0.75) CA2CA1CA12CA9CA7
SCHEMBL31060725 0.87 CA2 (1.00) CA2CA1CA12CA9CA7
SCHEMBL22029344 0.87 CA2 (0.75) CA2CA1CA12CA9CA7
SCHEMBL5527294 0.87 CA2 (0.75) CA2CA1CA12CA9CA7
SCHEMBL22029399 0.87 CA2 (0.75) CA2CA1CA12CA9CA7
SCHEMBL202948 0.85 CA2 (0.81) CA2CA1CA12CA9CA7
SCHEMBL6732192 0.83 CA2 (0.69) CA2CA1CA12CA9CA7
SCHEMBL28617027 0.83 CA2 (0.69) CA2CA1CA12CA9CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 669 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260022096-A1 NOVEL SULFONAMIDES AND THEIR USE AS NEUROPROTECTIVE AND/OR NEURORESTORATIVE AGENTS GENECODE (EE) 2026-01-22 US claimed
CN-119931287-A Oxazoline end capped polyester chain extension PLA/PBAT/TPS composite material and preparation method thereof 康辉新材料科技有限公司 2025-05-06 CN claimed
CN-119654040-A Method for regulating and controlling crystallization of perovskite material by vacuum vapor deposition 南京大学 2025-03-18 CN claimed
CN-119528773-A N-alkylation method of sulfonamide compound 赣南医科大学 2025-02-28 CN claimed
CN-118598779-A Preparation method of pH/hypoxia dual response type antitumor nano drug carrier 河南科技大学 2024-09-06 CN claimed
CN-114752939-B Etching solution and preparation method and application thereof 光华科学技术研究院(广东)有限公司 2024-07-16 CN claimed
CN-118125951-A Sulfonyl zwitterionic polymer with antibacterial function, and preparation method and application thereof 河南科技大学 2024-06-04 CN claimed
EP-3980770-B1 INDICATOR MATERIAL COMPRISING A POLYMERIC GEL CARRIER AND POLYMERIC INDICATOR MOOW FARM KFT (HU) 2024-01-24 EP claimed
CN-117187810-A Microetching roughening solution for high-frequency high-speed circuit board and application thereof 上海天承化学有限公司 2023-12-08 CN claimed
CN-116904084-A High-wear-resistance beryllium copper rod and preparation method thereof 江阴金湾合金材料有限公司 2023-10-20 CN claimed
CN-104109120-A N'-aryl acryloyl o-pyridine hydrazide derivatives, and preparation methods, pharmaceutical composition and application thereof INST MATERIA MEDICA CAMS 2014-10-22 CN claimed
CN-104109121-A N'-aryl acetyl o-pyridine hydrazide derivatives, and preparation methods, pharmaceutical composition and application thereof INST MATERIA MEDICA CAMS 2014-10-22 CN claimed
CN-101709045-B Preparation method of thiophenol UNIV ZHEJIANG 2013-02-27 CN claimed
CN-102643175-A Ruthenium complex ligand, ruthenium complex, supported ruthenium complex catalyst and preparation method and application thereof ZANNAN SCITECH CO LTD 2012-08-22 CN claimed
CN-101993416-A Quinoline compound and preparation method thereof, medicament combination containing compound and application of compound SHANGHAI INST MATERIA MEDICA 2011-03-30 CN claimed
CN-101709045-A Preparation method of thiophenol UNIV ZHEJIANG 2010-05-19 CN claimed
EP-1905777-A1 RUTHENIUM COMPLEX LIGAND, RUTHENIUM COMPLEX, CARRIED RUTHENIUM COMPLEX CATALYST AND THE PREPARING METHODS AND THE USE THEREOF Zhan, Zheng-Yun (CN) 2008-04-02 EP claimed
CN-1907992-A Ruthenium complex ligand, ruthenium complex, immobilized ruthenium complex catalyst, and preparation method and application thereof ZHENGYUN ZHAN (US) 2007-02-07 CN claimed
US-5516672-A CONTAINING A BENZENE DERIVATIVE AS STABILIZER; MEDICAL DIAGNOSIS; STORAGE STABILITY KONICA CORPORATION (JP) 1996-05-14 US claimed
US-5468587-A Water developable chromogenic photographic heat transferable non-aqueous dye diffusion transfer photographic element EASTMAN KODAK COMPANY (US) 1995-11-21 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260022096-A1 NOVEL SULFONAMIDES AND THEIR USE AS NEUROPROTECTIVE AND/OR NEURORESTORATIVE AGENTS CNR1, CDR2, SMN1; SMN2 CA2 240/4885CA1 93/4885CA12 271/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.